ChemSpider 2D Image | (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-30-{4-[(2S)-2-Butanyl]-1-piperazinyl}-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyc lo[23.11.1.1~4,7~.0~5,36~.0~26,35~.0~28,33~]octatriaconta-1(36),2,4,9,19,21,24,26(35),28,30,32-undecaen-13-yl acetate | C51H64N4O13

(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-30-{4-[(2S)-2-Butanyl]-1-piperazinyl}-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyc lo[23.11.1.14,7.05,36.026,35.028,33]octatriaconta-1(36),2,4,9,19,21,24,26(35),28,30,32-undecaen-13-yl acetate

  • Molecular FormulaC51H64N4O13
  • Average mass941.073 Da
  • Monoisotopic mass940.446960 Da
  • ChemSpider ID7848677

  • Double-bond stereo - Double-bond stereo

    defined stereocentres - 10 of 10 defined stereocentres

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-30-{4-[(2S)-2-Butanyl]-1-piperazinyl}-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyc ;lo[23.11.1.14,7.05,36.026,35.028,33]octatriaconta-1(36),2,4,9,19,21,24,26(35),28,30,32-undecaen-13-yl acetate [ACD/IUPAC Name]
(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-30-{4-[(2S)-2-Butanyl]-1-piperazinyl}-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23,37-trioxo-8,27,38-trioxa-24,34-diazahexacyc ;lo[23.11.1.14,7.05,36.026,35.028,33]octatriaconta-1(36),2,4,9,19,21,24,26(35),28,30,32-undecaen-13-yl-acetat [German] [ACD/IUPAC Name]
13H-2,7-(Epoxy[1,11,13]pentadecatrienonitrilo)-6H-benzofuro[4,5-a]phenoxazine-1,6,15(2H)-trione, 25-(acetyloxy)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-[4-[(1S)-1-methylpr opyl]-1-piperazinyl]-, (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)- [ACD/Index Name]
Acétate de (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-30-{4-[(2S)-2-butanyl]-1-pipérazinyl}-2,15,17,32-tétrahydroxy-11-méthoxy-3,7,12,14,16,18,22-heptaméthyl-6,23,37-trioxo-8,27,38-trioxa-24,34-d ;iazahexacyclo[23.11.1.14,7.05,36.026,35.028,33]octatriaconta-1(36),2,4,9,19,21,24,26(35),28,30,32-undécaén-13-yle [French] [ACD/IUPAC Name]
133698-17-6 [RN]
3'-Hydroxy-5'(S)-(4-sec-butylpiperazinyl)benzoxazinorifamycin
Rifamycin VIII, 1',4-didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-5'-(4-(1-methylpropyl)-1-piperazinyl)-1-oxo-, (5'(S))-
Rifamycin VIII, 1',4-didehydro-1-deoxy-1,4-dihydro-3'-hydroxy-5'-[4-(1-methylpropyl)-1-piperazinyl]-1-oxo-, [5'(S)]-

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

AIDS008666 [DBID]
AIDS-008666 [DBID]
Krm 1687 [DBID]
KRM-1687 [DBID]

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.4±0.1 g/cm3
Boiling Point: 1048.4±75.0 °C at 760 mmHg
Vapour Pressure: 0.0±0.3 mmHg at 25°C
Enthalpy of Vaporization: 160.7±3.0 kJ/mol
Flash Point: 587.8±37.1 °C
Index of Refraction: 1.634
Molar Refractivity: 246.0±0.5 cm3
#H bond acceptors: 17
#H bond donors: 5
#Freely Rotating Bonds: 6
#Rule of 5 Violations: 3
ACD/LogP: 2.80
ACD/LogD (pH 5.5): 2.32
ACD/BCF (pH 5.5): 8.71
ACD/KOC (pH 5.5): 32.33
ACD/LogD (pH 7.4): 1.96
ACD/BCF (pH 7.4): 3.79
ACD/KOC (pH 7.4): 14.05
Polar Surface Area: 226 Å2
Polarizability: 97.5±0.5 10-24cm3
Surface Tension: 49.0±7.0 dyne/cm
Molar Volume: 688.2±7.0 cm3

Click to predict properties on the Chemicalize site


Advertisement